SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUARDIGLI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.701
EU - Europa 456
AS - Asia 385
SA - Sud America 9
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.695
CN - Cina 189
UA - Ucraina 129
IT - Italia 111
SG - Singapore 110
DE - Germania 72
TR - Turchia 66
GB - Regno Unito 47
SE - Svezia 30
FI - Finlandia 29
ID - Indonesia 12
FR - Francia 10
DK - Danimarca 7
IE - Irlanda 4
BE - Belgio 3
BO - Bolivia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IN - India 3
CA - Canada 2
CH - Svizzera 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CU - Cuba 1
EG - Egitto 1
IM - Isola di Man 1
KR - Corea 1
LU - Lussemburgo 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 2.555
Salva come PNG Salva come JPEG
Città #
Woodbridge 209
Chandler 174
Fairfield 167
Jacksonville 149
Houston 123
Ashburn 108
Ann Arbor 88
Singapore 77
Wilmington 74
Seattle 65
Nanjing 50
Cambridge 46
Princeton 44
Izmir 43
Shanghai 30
Boardman 27
San Diego 26
Beijing 25
Milan 22
New York 22
Ferrara 21
Bremen 19
Santa Clara 13
Shenyang 13
Jakarta 12
Falls Church 11
Bologna 9
Jiaxing 8
Nanchang 8
Changsha 7
Dearborn 7
Hebei 7
Acireale 6
Kunming 6
Odense 6
Redwood City 6
Tianjin 6
Addison 5
Naples 5
San Mateo 5
Jinan 4
Los Angeles 4
Ningbo 4
Orange 4
Poggio Renatico 4
Brussels 3
Dublin 3
Edinburgh 3
Mountain View 3
Parma 3
Rimini 3
Zhengzhou 3
Aversa 2
Brno 2
Brugherio 2
Bucharest 2
Des Moines 2
Forest City 2
Hong Kong 2
Indiana 2
Lappeenranta 2
Leawood 2
Lima 2
London 2
Lugano 2
Norwalk 2
Piacenza 2
Rome 2
San Salvador 2
Sassari 2
Taizhou 2
Tappahannock 2
Verona 2
Washington 2
Alcobaça 1
Atlanta 1
Auburn Hills 1
Auckland 1
Augusta 1
Bandar Seri Begawan 1
Bethesda 1
Bogotá 1
Buenos Aires 1
Cairo 1
Celbridge 1
Chengdu 1
Chicago 1
Chiswick 1
Copenhagen 1
Douglas 1
Edmonton 1
Florence 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Heredia 1
Hyderabad 1
Kilburn 1
Lanzhou 1
Totale 1.860
Salva come PNG Salva come JPEG
Nome #
Reperfusion Damage - A Story of Success, Failure, and Hope 126
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 110
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 107
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 104
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 104
Oxidative stress during myocardial ischaemia and heart failure 91
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 90
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 90
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 89
The heart rate story 89
Angiotensin II overproduction: enemy of the vessel wall 87
A modern fairy tale 83
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. 82
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 81
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 75
[Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention] 72
Tirofiban: a critical reappraisal of the clinical use, recent developpements and future perspectives. 72
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 71
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 64
Bradykinin and coronary artery disease 62
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 62
null 61
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 56
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 54
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 54
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 52
Ferrara VI 50
LEFT VENTRICULAR REMODELLING AT THE LIMITS 47
FERRARA: CITTÀ DELLA PREVENZIONE 46
Safety and efficacy of new-generation coronary bioresorbable scaffolds 37
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 37
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 37
Ferrara II 36
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 33
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 32
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 31
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 28
The future of cardiovascular prevention: between fiction and reality 23
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 19
[Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 18
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 16
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 10
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 7
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 7
MULTIMODALITY IMAGING IN ACROMEGALIC CARDIOMIOPATHY: A CASE REPORT 7
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 6
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 6
One-year outcome of elderly patients with endocarditis: a retrospective observational study 6
Totale 2.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 246
Totale 15.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 60 25 50 32 45 29 56 13 8
2020/2021311 30 50 10 38 18 28 3 38 7 35 39 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/2025150 23 35 87 5 0 0 0 0 0 0 0 0
Totale 2.627